Baseline and longitudinal plasma caveolin‐1 level as a biomarker in active surveillance for early‐stage prostate cancer

Objectives To evaluate the role of caveolin‐1 (Cav‐1) as a predictor of disease reclassification (DR) in men with early prostate cancer undergoing active surveillance (AS). Patients and Methods We analysed archived plasma samples prospectively collected from patients with early prostate cancer in a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BJU international 2018-01, Vol.121 (1), p.69-76
Hauptverfasser:	Basourakos, Spyridon P., Davis, John W., Chapin, Brian F., Ward, John F., Pettaway, Curtis A., Pisters, Louis L., Navai, Neema, Achim, Mary F., Wang, Xuemei, Chen, Hsiang‐Chun, Choi, Seungtaek, Kuban, Deborah, Troncoso, Patricia, Hanash, Sam, Thompson, Timothy C., Kim, Jeri
Format:	Artikel
Sprache:	eng
Schlagworte:	active surveillance Aged Analysis of Variance biomarkers Biomarkers, Tumor - blood Caveolin Caveolin 1 - blood Caveolin-1 Cohort Studies Disease Progression Enzyme-Linked Immunosorbent Assay Humans Logistic Models Longitudinal Studies Male Middle Aged Multivariate Analysis Neoplasm Grading PCSM Plasma Predictive Value of Tests Prognosis Prospective Studies Prostate cancer Prostate-specific antigen Prostate-Specific Antigen - blood ProstateCancer Prostatic Neoplasms - blood Prostatic Neoplasms - pathology Prostatic Neoplasms - physiopathology Reclassification Risk assessment Surveillance Tumors watchful waiting Watchful Waiting - methods
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!